McDonald, Marguerite B <br/><br/>
Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.  [electronic resource] 

 -  Ophthalmology  Sep 2009 
 - 1615-1623.e1 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-4713 
<br/><br/><label>Standard No.: </label>10.1016/j.ophtha.2009.05.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--administration & dosage<br/>Aza Compounds--administration & dosage<br/>Azepines--administration & dosage<br/>Child<br/>Child, Preschool<br/>Conjunctiva--microbiology<br/>Conjunctivitis, Bacterial--drug therapy<br/>Double-Blind Method<br/>Female<br/>Fluoroquinolones--administration & dosage<br/>Haemophilus influenzae--isolation & purification<br/>Humans<br/>Infant<br/>Male<br/>Microscopy, Acoustic<br/>Middle Aged<br/>Moxifloxacin<br/>Ophthalmic Solutions--administration & dosage<br/>Quinolines--administration & dosage<br/>Staphylococcus aureus--isolation & purification<br/>Staphylococcus epidermidis--isolation & purification<br/>Streptococcus pneumoniae--isolation & purification<br/>Treatment Outcome<br/>Visual Acuity